NCT06709300View on ClinicalTrials.gov

An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular Hypertension

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2026

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions
Ocular Hypertension
Trial Locations (1)

4005

Ophthalmic Trials Australia, Brisbane

Sponsors
All Listed Sponsors
collaborator

EyeCool Therapeutics, Pty Ltd

UNKNOWN

lead

EyeCool Therapeutics, Inc.

INDUSTRY